India's drug regulator tightened surveillance against unauthorized sale and promotion of weight-loss drugs, the country's health ministry said on Tuesday, following local drugmakers launching a wave of generic, cheaper versions of Novo Nordisk's blockbuster drugs Ozempic and Wegovy.
India's drug regulator tightens surveillance against unauthorized weight-loss drug sales
